On the other hand, FUS::NFATC2-translocated sarcomas exhibited very complex genomic profiles, while in those cases harboring ESWR1::NFATC2 fusion, fewer genomic alterations were found [6,7,13]. This evidence concerns the gene FUS and sarcoma.